drugset / Trial / NCT04513509

Rate Control in Patients With Atrial Fibrillation

NCT04513509

Completed 13 enrolled National Taiwan University Hospital
NaSequentialOpen-labelTreatment

Summary

To search for the best marker for the patients in atrial fibrillation with rate control

Timeline

Start
2020-10-21
Primary completion
2022-06-21
Completion
2022-07-01

Drugs

EvaluationDrugModalityDoseRoute
Subject Atenolol Other / unclassified
Subject Bisoprolol Other / unclassified
Subject Digoxin Other / unclassified
Subject Diltiazem Small molecule
Subject Metoprolol Other / unclassified
Subject Nebivolol Other / unclassified
Subject Propranolol Small molecule
Subject Verapamil Other / unclassified

Indications